Batool F Kirmani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Batool F Kirmani

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Frontiers in Neurology|June 6, 2018

Management of Autoimmune Status EpilepticusBatool F Kirmani, Donald Barr, Diana Mungall Robinson, et al.

Neuroscience Insights|September 30, 2024

Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying TherapiesMary Hollist, Abraham Hollist, Katherine Au, et al.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 27, 2016

Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple SclerosisJie Wen, Prasanth S Ariyannur, Rachel Ribeiro, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Frontiers in Neurology|June 6, 2018

Management of Autoimmune Status EpilepticusBatool F Kirmani, Donald Barr, Diana Mungall Robinson, et al.

Neuroscience Insights|September 30, 2024

Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying TherapiesMary Hollist, Abraham Hollist, Katherine Au, et al.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 27, 2016

Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple SclerosisJie Wen, Prasanth S Ariyannur, Rachel Ribeiro, et al.

Pageof 3